Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ISRCTN67592622) titled 'A two-part study to investigate the effects in adults of two doses of golexanolone in patients with primary biliary cholangitis with fatigue and cognitive dysfunction' on Dec. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Umecrine Cognition AB
Condition:
Patients with primary biliary cholangitis with fatigue and cognitive dysfunction
Digestive System
Intervention:
This is a multicenter interventional randomised, double-blind, placebo-controlled, two-part Phase Ib/2a...